
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Oncology, Markers, Clinical Correlates |
Department of Pathology, University of Cambridge, Cambridge CB2 1QP [A. F., L. S. M., G. H. W., N. C.]; Wellcome Trust/Cancer Research Campaign Institute, Cambridge CB2 1QR [A. F., L. S. M., A. D. M., K. S., R. A. L., G. H. W.]; and Department of Zoology, University of Cambridge, Cambridge CB2 3EJ [A. D. M., K. S., R. A. L.], United Kingdom
Dysplasia, an intermediate stage in the progression from normal tissue to neoplasia, is defined morphologically by a loss of normal orientation between epithelial cells, with changes in cellular and nuclear shape and size. However, little is known about the functional properties of dysplastic cells, including their replicative state, largely due to a lack of available biological markers. We have used novel antibodies against minichromosome maintenance (MCM) proteins to examine the proliferative status of a range of histological lesions and to characterize dysplastic cells in functional terms.
Immunoperoxidase staining was used to localize the MCM proteins, components of the prereplicative complex that is essential for initiating eukaryotic DNA replication. These proteins are down-regulated in cells undergoing differentiation or quiescence and, thus, serve as specific markers for proliferating cells.
In normal and some reactive tissues, MCM expression was present only in restricted proliferative compartments, consistent with our published findings in the uterine cervix. In dysplastic and malignant tissues, in contrast, MCM proteins were expressed in the majority of cells, extending to surface layers of dysplastic stratified epithelia. In carcinomas, the frequency of expression of MCM proteins showed an inverse correlation with the degree of tumor differentiation. Thus, we suggest that dysplastic cells may be characterized in functional terms as remaining in cell cycle, due to deregulation of normal controls over cell proliferation.
Antibodies against MCM proteins have potential clinical applications, for example, in the assessment of tumor prognosis in histological sections and the identification of proliferating cells in clinical samples using biochemical or cytological assays.
This article has been cited by other articles:
![]() |
A Hanna-Morris, S Badvie, P Cohen, T McCullough, H J N Andreyev, and T G Allen-Mersh Minichromosome maintenance protein 2 (MCM2) is a stronger discriminator of increased proliferation in mucosa adjacent to colorectal cancer than Ki-67 J. Clin. Pathol., April 1, 2009; 62(4): 325 - 330. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Conesa-Zamora, A Domenech-Peris, S Ortiz-Reina, F J Orantes-Casado, J Acosta-Ortega, J Garcia-Solano, and M Perez-Guillermo Immunohistochemical evaluation of ProEx C in human papillomavirus-induced lesions of the cervix J. Clin. Pathol., February 1, 2009; 62(2): 159 - 162. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. NOWAK, J. A. MADEJ, and P. DZIEGIEL Correlation Between MCM-3 Protein Expression and Grade of Malignancy in Mammary Adenocarcinomas and Soft Tissue Fibrosarcomas in Dogs In Vivo, January 1, 2009; 23(1): 49 - 53. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Scarpini, V. White, B. Muralidhar, A. Patterson, N. Hickey, N. Singh, J. Mullerat, M. Winslet, R. J. Davies, M.-L. Phillips, et al. Improved Screening for Anal Neoplasia by Immunocytochemical Detection of Minichromosome Maintenance Proteins Cancer Epidemiol. Biomarkers Prev., October 1, 2008; 17(10): 2855 - 2864. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. H. Lu, J. D. Wright, B. Belt, R. D. Cardiff, and J. M. Arbeit Hypoxia-Inducible Factor-1 Facilitates Cervical Cancer Progression in Human Papillomavirus Type 16 Transgenic Mice Am. J. Pathol., August 1, 2007; 171(2): 667 - 681. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C Obermann, P. Went, A. Tzankov, S. A Pileri, F. Hofstaedter, J. Marienhagen, R. Stoehr, and S. Dirnhofer Cell cycle phase distribution analysis in chronic lymphocytic leukaemia: a significant number of cells reside in early G1-phase J. Clin. Pathol., July 1, 2007; 60(7): 794 - 797. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Y. Maslov, K. J. Bailey, L. M. Mielnicki, A. L. Freeland, X. Sun, W. C. Burhans, and S. C. Pruitt Stem/Progenitor Cell-Specific Enhanced Green Fluorescent Protein Expression Driven by the Endogenous Mcm2 Promoter Stem Cells, January 1, 2007; 25(1): 132 - 138. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Mohan, M Kandalam, H L Ramkumar, L Gopal, and S Krishnakumar Stem cell markers: ABCG2 and MCM2 expression in retinoblastoma Br. J. Ophthalmol., July 1, 2006; 90(7): 889 - 893. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Lao-Sirieix, A. Roy, C. Worrall, S. L. Vowler, S. Gardiner, and R. C. Fitzgerald Effect of Acid suppression on molecular predictors for esophageal cancer. Cancer Epidemiol. Biomarkers Prev., February 1, 2006; 15(2): 288 - 293. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Guida, G. Salvatore, P. Faviana, R. Giannini, G. Garcia-Rostan, L. Provitera, F. Basolo, A. Fusco, F. Carlomagno, and M. Santoro Mitogenic Effects of the Up-Regulation of Minichromosome Maintenance Proteins in Anaplastic Thyroid Carcinoma J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4703 - 4709. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Laskey The Croonian Lecture 2001 Hunting the antisocial cancer cell: MCM proteins and their exploitation Phil Trans R Soc B, June 29, 2005; 360(1458): 1119 - 1132. [Abstract] [Full Text] [PDF] |
||||
![]() |
N Murphy, M Ring, C C B B Heffron, B King, A G Killalea, C Hughes, C M Martin, E McGuinness, O Sheils, and J J O'Leary p16INK4A, CDC6, and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancer J. Clin. Pathol., May 1, 2005; 58(5): 525 - 534. [Abstract] [Full Text] [PDF] |
||||
![]() |
V Ananthanarayanan, M R Pins, R E Meyer, and P H Gann Immunohistochemical assays in prostatic biopsies processed in Bouin's fixative J. Clin. Pathol., March 1, 2005; 58(3): 322 - 324. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-A. Ha, S. M. Shin, H. Namkoong, H. Lee, G. W. Cho, S. Y. Hur, T. E. Kim, and J. W. Kim Cancer-Associated Expression of Minichromosome Maintenance 3 Gene in Several Human Cancers and Its Involvement in Tumorigenesis Clin. Cancer Res., December 15, 2004; 10(24): 8386 - 8395. [Abstract] [Full Text] [PDF] |
||||
![]() |
S J Langlands, M J Hopkins, N Coleman, and J H Cummings Prebiotic carbohydrates modify the mucosa associated microflora of the human large bowel Gut, November 1, 2004; 53(11): 1610 - 1616. [Abstract] [Full Text] [PDF] |
||||
![]() |
V Padmanabhan, P Callas, G Philips, T D Trainer, and B G Beatty DNA replication regulation protein Mcm7 as a marker of proliferation in prostate cancer J. Clin. Pathol., October 1, 2004; 57(10): 1057 - 1062. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Polo, S. E. Theocharis, J. Klijanienko, A. Savignoni, B. Asselain, P. Vielh, and G. Almouzni Chromatin Assembly Factor-1, a Marker of Clinical Value to Distinguish Quiescent from Proliferating Cells Cancer Res., April 1, 2004; 64(7): 2371 - 2381. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Forsburg Eukaryotic MCM Proteins: Beyond Replication Initiation Microbiol. Mol. Biol. Rev., March 1, 2004; 68(1): 109 - 131. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Y. Maslov, T. A. Barone, R. J. Plunkett, and S. C. Pruitt Neural Stem Cell Detection, Characterization, and Age-Related Changes in the Subventricular Zone of Mice J. Neurosci., February 18, 2004; 24(7): 1726 - 1733. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Brake, J. P. Connor, D. G. Petereit, and P. F. Lambert Comparative Analysis of Cervical Cancer in Women and in a Human Papillomavirus-Transgenic Mouse Model: Identification of Minichromosome Maintenance Protein 7 as an Informative Biomarker for Human Cervical Cancer Cancer Res., December 1, 2003; 63(23): 8173 - 8180. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Gonzalez, S. E. Pinder, G. Callagy, S. L. Vowler, L. S. Morris, K. Bird, J. A. Bell, R. A. Laskey, and N. Coleman Minichromosome Maintenance Protein 2 Is a Strong Independent Prognostic Marker in Breast Cancer J. Clin. Oncol., December 1, 2003; 21(23): 4306 - 4313. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Khalili, L. Del Valle, V. Muralidharan, W. J. Gault, N. Darbinian, J. Otte, E. Meier, E. M. Johnson, D. C. Daniel, Y. Kinoshita, et al. Pur{alpha} Is Essential for Postnatal Brain Development and Developmentally Coupled Cellular Proliferation As Revealed by Genetic Inactivation in the Mouse Mol. Cell. Biol., October 1, 2003; 23(19): 6857 - 6875. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Middleton, W. Peh, S. Southern, H. Griffin, K. Sotlar, T. Nakahara, A. El-Sherif, L. Morris, R. Seth, M. Hibma, et al. Organization of Human Papillomavirus Productive Cycle during Neoplastic Progression Provides a Basis for Selection of Diagnostic Markers J. Virol., October 1, 2003; 77(19): 10186 - 10201. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Sirieix, M. O'Donovan, J. Brown, V. Save, N. Coleman, and R. C. Fitzgerald Surface Expression of Minichromosome Maintenance Proteins Provides a Novel Method for Detecting Patients at Risk for Developing Adenocarcinoma in Barrett's Esophagus Clin. Cancer Res., July 1, 2003; 9(7): 2560 - 2566. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Johnson, Y. Kinoshita, and D. C. Daniel A new member of the MCM protein family encoded by the human MCM8 gene, located contrapodal to GCD10 at chromosome band 20p12.3-13 Nucleic Acids Res., June 1, 2003; 31(11): 2915 - 2925. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Gozuacik, M. Chami, D. Lagorce, J. Faivre, Y. Murakami, O. Poch, E. Biermann, R. Knippers, C. Brechot, and P. Paterlini-Brechot Identification and functional characterization of a new member of the human Mcm protein family: hMcm8 Nucleic Acids Res., January 15, 2003; 31(2): 570 - 579. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Stoeber, R. Swinn, A. T. Prevost, P. de Clive-Lowe, I. Halsall, S. M. Dilworth, J. Marr, W. H. Turner, N. Bullock, A. Doble, et al. Diagnosis of Genito-Urinary Tract Cancer by Detection of Minichromosome Maintenance 5 Protein in Urine Sediments J Natl Cancer Inst, July 17, 2002; 94(14): 1071 - 1079. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Rodins, M. Cheale, N. Coleman, and S. B. Fox Minichromosome Maintenance Protein 2 Expression in Normal Kidney and Renal Cell Carcinomas: Relationship to Tumor Dormancy and Potential Clinical Utility Clin. Cancer Res., April 1, 2002; 8(4): 1075 - 1081. [Abstract] [Full Text] [PDF] |
||||
![]() |
M R Alison, T Hunt, and S J Forbes Minichromosome maintenance (MCM) proteins may be pre-cancer markers Gut, March 1, 2002; 50(3): 290 - 291. [Full Text] [PDF] |
||||
![]() |
J. M. Shohet, M. J. Hicks, S. E. Plon, S. M. Burlingame, S. Stuart, S.-Y. Chen, M. K. Brenner, and J. G. Nuchtern Minichromosome Maintenance Protein MCM7 Is a Direct Target of the MYCN Transcription Factor in Neuroblastoma Cancer Res., February 1, 2002; 62(4): 1123 - 1128. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ramnath, F. J. Hernandez, D.-F. Tan, J. A. Huberman, N. Natarajan, A. F. Beck, A. Hyland, I. T. Todorov, J. S.J. Brooks, and G. Bepler MCM2 Is an Independent Predictor of Survival in Patients With Non-Small-Cell Lung Cancer J. Clin. Oncol., November 15, 2001; 19(22): 4259 - 4266. [Abstract] [Full Text] |
||||
![]() |
D. S. Rickman, M. P. Bobek, D. E. Misek, R. Kuick, M. Blaivas, D. M. Kurnit, J. Taylor, and S. M. Hanash Distinctive Molecular Profiles of High-Grade and Low-Grade Gliomas Based on Oligonucleotide Microarray Analysis Cancer Res., September 1, 2001; 61(18): 6885 - 6891. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. V. Meng, G. D. Grossfeld, G. H. Williams, S. Dilworth, K. Stoeber, T. W. Mulley, V. Weinberg, P. R. Carroll, and T. D. Tlsty Minichromosome Maintenance Protein 2 Expression in Prostate: Characterization and Association with Outcome after Therapy for Cancer Clin. Cancer Res., September 1, 2001; 7(9): 2712 - 2718. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Stoeber, T. D. Tlsty, L. Happerfield, G. A. Thomas, S. Romanov, L. Bobrow, E. D. Williams, and G. H. Williams DNA replication licensing and human cell proliferation J. Cell Sci., January 6, 2001; 114(11): 2027 - 2041. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Doorbar, R. C. Elston, S. Napthine, K. Raj, E. Medcalf, D. Jackson, N. Coleman, H. M. Griffin, P. Masterson, S. Stacey, et al. The E1and E4 Protein of Human Papillomavirus Type 16 Associates with a Putative RNA Helicase through Sequences in Its C Terminus J. Virol., November 1, 2000; 74(21): 10081 - 10095. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |